2’-(Methylthio)-7’,8’-Dihydro-6’H-Spiro[Cyclohexane-1,9’-Pyrazino[1’,2’:1,5]Pyrrolo[2,3-D]Pyrimidin]-6’-One
97%
- Product Code: 212871
CAS:
2170747-00-7
Molecular Weight: | 302.39 g./mol | Molecular Formula: | C₁₅H₁₈N₄OS |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting cancer-related enzymes such as PI3K and mTOR. Its spirocyclic structure enhances binding selectivity and metabolic stability, making it valuable in developing targeted therapies. Also explored in the design of anti-inflammatory and neuroprotective agents due to its ability to cross the blood-brain barrier. Commonly modified to improve solubility and bioavailability in drug candidates.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | ฿153,600.00 |
+
-
|
2’-(Methylthio)-7’,8’-Dihydro-6’H-Spiro[Cyclohexane-1,9’-Pyrazino[1’,2’:1,5]Pyrrolo[2,3-D]Pyrimidin]-6’-One
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting cancer-related enzymes such as PI3K and mTOR. Its spirocyclic structure enhances binding selectivity and metabolic stability, making it valuable in developing targeted therapies. Also explored in the design of anti-inflammatory and neuroprotective agents due to its ability to cross the blood-brain barrier. Commonly modified to improve solubility and bioavailability in drug candidates.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :